227 related articles for article (PubMed ID: 26886646)
21. Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies.
Vijayant V; Sarma M; Aurangabadkar H; Bichile L; Basu S
World J Radiol; 2012 Dec; 4(12):462-8. PubMed ID: 23320137
[TBL] [Abstract][Full Text] [Related]
22. Prospective Comparison of Angiogenesis-Specific 68Ga-RGD2 PET/CT Imaging Parameters and DAS28-ESR in Rheumatoid Arthritis.
Kavanal AJ; Bhattacharya A; Sharma A; Shukla J; Chattopadhyay A; M B A; Sharma V; Vatsa R; Rana N; Kaur G; Mittal BR
Clin Nucl Med; 2021 Jul; 46(7):556-561. PubMed ID: 33782288
[TBL] [Abstract][Full Text] [Related]
23. Reappraisal of bone scintigraphy as a new tool for the evaluation of disease activity in patients with rheumatoid arthritis.
Lee SJ; Hong CM; Cho I; Ahn BC; Eun JS; Kim NR; Kang JW; Kang YM
Sci Rep; 2021 Nov; 11(1):21809. PubMed ID: 34750402
[TBL] [Abstract][Full Text] [Related]
24.
Reddy N; Raynor WY; Werner TJ; Baker JF; Alavi A; Revheim ME
Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443544
[TBL] [Abstract][Full Text] [Related]
25. Comparison of methods of quantifying global synovial metabolic activity with FDG-PET/CT in rheumatoid arthritis.
Raynor WY; Jonnakuti VS; Zirakchian Zadeh M; Werner TJ; Cheng G; Zhuang H; Høilund-Carlsen PF; Alavi A; Baker JF
Int J Rheum Dis; 2019 Dec; 22(12):2191-2198. PubMed ID: 31721461
[TBL] [Abstract][Full Text] [Related]
26. Development and evaluation of a novel ultrasound score for large joints in rheumatoid arthritis: one year of experience in daily clinical practice.
Hartung W; Kellner H; Strunk J; Sattler H; Schmidt WA; Ehrenstein B; Fleck M; Backhaus M
Arthritis Care Res (Hoboken); 2012 May; 64(5):675-82. PubMed ID: 22183834
[TBL] [Abstract][Full Text] [Related]
27. Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs.
Roivainen A; Hautaniemi S; Möttönen T; Nuutila P; Oikonen V; Parkkola R; Pricop L; Ress R; Seneca N; Seppänen M; Yli-Kerttula T
Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):403-10. PubMed ID: 23229747
[TBL] [Abstract][Full Text] [Related]
28. Arterial Inflammation Detected With
Geraldino-Pardilla L; Zartoshti A; Bag Ozbek A; Giles JT; Weinberg R; Kinkhabwala M; Bokhari S; Bathon JM
Arthritis Rheumatol; 2018 Jan; 70(1):30-39. PubMed ID: 28992382
[TBL] [Abstract][Full Text] [Related]
29. Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Trang DAMT; Okamura K; Suto T; Sakane H; Yonemoto Y; Nakajima T; Tsushima Y; Chikuda H
Arthritis Res Ther; 2021 Aug; 23(1):206. PubMed ID: 34344436
[TBL] [Abstract][Full Text] [Related]
30. 18F-FDG PET-CT in rheumatoid arthritis patients tapering TNFi: reliability, validity and predictive value.
Bouman CAM; van Herwaarden N; Blanken AB; Van der Laken CJ; Gotthardt M; Oyen WJG; den Broeder AA; van der Maas A; van den Ende CH
Rheumatology (Oxford); 2022 Apr; 61(SI):SI6-SI13. PubMed ID: 34791068
[TBL] [Abstract][Full Text] [Related]
31. Clinical features of atlantoaxial involvement in patients with rheumatoid arthritis using
Noguchi A; Kurita T; Matsuzawa K
Clin Rheumatol; 2023 Jul; 42(7):1875-1884. PubMed ID: 37000282
[TBL] [Abstract][Full Text] [Related]
32. Effect of total knee arthroplasty on other joints in patients with rheumatoid arthritis evaluated by 18-FDG-PET.
Yonemoto Y; Okamura K; Kaneko T; Okura C; Kobayashi T; Suto T; Tsushima Y; Takagishi K
Int J Rheum Dis; 2017 Jun; 20(6):702-707. PubMed ID: 26991010
[TBL] [Abstract][Full Text] [Related]
33. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET.
Beckers C; Ribbens C; André B; Marcelis S; Kaye O; Mathy L; Kaiser MJ; Hustinx R; Foidart J; Malaise MG
J Nucl Med; 2004 Jun; 45(6):956-64. PubMed ID: 15181130
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography/computed tomography imaging and rheumatoid arthritis.
Wang SC; Xie Q; Lv WF
Int J Rheum Dis; 2014 Mar; 17(3):248-55. PubMed ID: 24606324
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors related to shoulder joint destruction in rheumatoid arthritis patients treated with biologics: A prospective study.
Yonemoto Y; Okamura K; Kobayashi T; Kaneko T; Okura C; Suto T; Tachibana M; Tsushima Y; Takagishi K
Mod Rheumatol; 2017 Jul; 27(4):587-592. PubMed ID: 27785938
[TBL] [Abstract][Full Text] [Related]
36. Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis.
Kubota K; Yamashita H; Mimori A
Semin Nucl Med; 2017 Jul; 47(4):408-424. PubMed ID: 28583280
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of golimumab for preventing large joint destruction in patients with rheumatoid arthritis as determined by the ARASHI score.
Kanbe K; Oh K; Chiba J; Inoue Y; Taguchi M; Yabuki A
Mod Rheumatol; 2017 Nov; 27(6):938-945. PubMed ID: 28121204
[TBL] [Abstract][Full Text] [Related]
38. Total-Body
Abdelhafez Y; Raychaudhuri SP; Mazza D; Sarkar S; Hunt HL; McBride K; Nguyen M; Caudle DT; Spencer BA; Omidvari N; Bang H; Cherry SR; Nardo L; Badawi RD; Chaudhari AJ
J Nucl Med; 2022 Oct; 63(10):1579-1585. PubMed ID: 35589405
[TBL] [Abstract][Full Text] [Related]
39. Arthritis of the large joints - in particular, the knee - at first presentation is predictive for a high level of radiological destruction of the small joints in rheumatoid arthritis.
Linn-Rasker SP; van der Helm-van Mil AH; Breedveld FC; Huizinga TW
Ann Rheum Dis; 2007 May; 66(5):646-50. PubMed ID: 17142384
[TBL] [Abstract][Full Text] [Related]
40. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
